Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

Venlafaxine HCL ER Capsule USP

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Terminated Dissolution failure Zydus Pharmaceuticals USA Inc NDC 68382-035-06 D-1461-2016
Class II · Moderate risk

Venlafaxine HCL ER Capsule USP

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Terminated Dissolution failure Zydus Pharmaceuticals USA Inc NDC 68382-036-06 D-1460-2016
Class II · Moderate risk

Trokendi XR

Superpotent Drug: Failure of assay specifications in the capsule.

Terminated Wrong potency / content Supernus Pharmaceuticals, Inc. NDC 17772-102-15 D-0112-2017

Recalls by year